TMDX

Q: What is the price of TransMedics Group (TMDX) today?

The price of TransMedics Group (TMDX) today is US$ 107,29, with a variation of -21.05% compared to the last year. The price of TransMedics Group (TMDX) started the year trading around US$ 62,35 and today it is at US$ 107,29. Follow the real-time price chart, the historical price of TransMedics Group (TMDX), and stock data from Ibovespa and international markets.

Q: When does TransMedics Group (TMDX) pay dividends?

TransMedics Group (TMDX) did not distribute dividends in the last year.

Q: TransMedics Group (TMDX) is it worth it?

Currently, TransMedics Group (TMDX) is priced at US$ 107,29, with a P/E of 38,43%, representing a deviation of -2,33% from its historical average P/E. In the last year, the stock showed a variation of -21.05% in its price and distributed US$ 0,00 in dividends, resulting in a Dividend Yield of 0,00%. The total shareholder return was -21,05%.It is important to remember that past performance does not guarantee future results. This should not be seen as an investment recommendation.

Q: How to buy stocks of TransMedics Group (TMDX)?

Investing in stocks of TransMedics Group (TMDX) can be done in two ways: by buying the stock no exterior. A stock is the original stock, traded on international exchanges. By buying it, you invest with money outside Brazil, which brings greater geographical and currency diversification.BDR is a receipt for that stock, traded on the B3 with reais, through a brazilian brokerage. Although the money remains in Brazil, the BDR still offers diversification, as it represents a foreign company and is linked to the dollar.

Q: How much do 100 stocks of TransMedics Group (TMDX) yield today?

The yield of TransMedics Group (TMDX) was -0,46% in the last month, -21,05% in the last year and 0,00% in the last 5 years (already considering appreciation and dividends).In the last 12 months, the company paid a total of US$ 0,00 in dividends, um Dividend Yield de 0,00%.If you wanted to buy 100 stocks of TransMedics Group (TMDX) today, the total investment would be US$ 10.729,00, based on the current price of US$ 107,29.If past performance were to repeat, the return on your investment would be:In 1 year: US$ 8.470,55In 5 years: US$ 10.729,00In 10 years: 10.729,00It is important to remember that past performance does not guarantee future results. This should not be seen as an investment recommendation.

TransMedics Group Inc.

Price

US$ 107,29

variation (12m)

-21,05%

p/l

38,43

p/vp

12,37

DIVIDEND YIELD

0,00%

price TMDX

BVMF

TMDX

If you had invested

years ago

6 months

1 year

5 years

10 years

ago, today you would have

ago, today you would have:

*The figure considers the reinvestment of dividends.

Profitability of TMDX

1 month

3 months

1 year

2 years

5 years

10 years

profitability

1 month

-0,46%

3 months

-4,60%

1 year

-21,05%

2 years

137,74%

5 years

0,00%

10 years

0,00%

real profitability

profitability minus inflation.

1 month

-0,46%

3 months

-4,95%

1 year

-24,51%

2 years

116,99%

5 years

0,00%

10 years

0,00%

Indicators TMDX

check out the fundamentals of TransMedics Group shares

P/E

38,43

Sector: -1,19 Industry: -3,13

P/SALES RATIO (PSR)

6,78

Sector: 1,95 Industry: 2,78

P/BV

12,37

Sector: 2,22 Industry: 1,88

DIVIDEND YIELD (DY)

0,00%

Sector: - Industry: -

ROA

11,49%

Sector: -26,82% Industry: -52,06%

ROE

32,18%

Sector: -29,98% Industry: -40,51%

ROIC

30,86%

Sector: -411,56% Industry: -412,66%

NET MARGIN

17,65%

Sector: -27,32% Industry: -30,04%

GROSS MARGIN

60,94%

Sector: 43,14% Industry: 44,05%

OPERATING MARGIN

18,83%

Sector: -23,36% Industry: -26,70%

P/EBITDA

27,07

Sector: 0,02 Industry: -2,09

P/EBIT

32,77

Sector: -1,26 Industry: -2,90

P/ASSET

4,42

Sector: 1,27 Industry: 1,41

BVPS

9,36

Sector: 3,73 Industry: 1,64

EPS

3,01

Sector: -0,77 Industry: -1,17

EQUITY / ASSETS

0,36

Sector: 0,45 Industry: 0,48

CAGR REVENUES 5 YEARS

87,24%

Sector: - Industry: -

CAGR PROFITS 5 YEARS

0,00%

Sector: - Industry: -

FAIR PRICE OF TransMedics Group ASSETS ACCORDING TO BENJAMIN GRAHAM

Graham's Fair Price

The Fair Price formula was created by Benjamin Graham to identify stocks with appreciation potential or that are being traded for less than they are worth. Graham was one of the greatest investors in history and Warren Buffet's mentor.

Current price

US$ 107,29

Fair Price

US$ 0,00

Upside Potencial de rentabilidade.

-76,53%

See Graham's ranking

Because it considers equity value in its calculation, the formula does not work well for technology companies.

This is not a buy/sell recommendation; the fair value calculation takes into account only the formula created by Benjamin Graham, published in the book The Intelligent Investor.

TMDX indicators history

DRAG THE FRAME TO SEE MORE DATA

Stocks comparator

DRAG THE FRAME TO SEE MORE DATA

	p/l	p/vp	ROE	dy	market value	net margin
LLY	54,65	41,10	75,21%	0,69%	US$ 754,20 B	25,91%
ISRG	60,13	9,05	15,04%	0,00%	US$ 162,39 B	28,29%
TMO	31,25	4,06	12,99%	0,30%	US$ 205,37 B	15,12%
SNY	7,88	1,54	19,52%	4,35%	US$ 124,76 B	22,40%
MDT	26,88	2,60	9,68%	2,88%	US$ 125,25 B	13,63%
CVS	17,95	1,27	7,05%	3,43%	US$ 98,10 B	1,40%
ABT	16,70	4,59	27,50%	1,73%	US$ 233,46 B	32,43%
NVS	17,78	6,13	34,49%	2,92%	US$ 257,90 B	25,52%
GSK	13,33	4,47	33,57%	3,74%	US$ 87,13 B	15,70%
BSX	50,82	6,36	12,51%	0,00%	US$ 144,03 B	14,65%
HCA	16,16	-82,92	-513,25%	0,66%	US$ 102,66 B	8,61%
DHR	48,94	2,95	6,02%	0,55%	US$ 154,15 B	13,04%
INMD	6,18	1,52	24,58%	0,00%	US$ 954,45 M	42,09%
IDXX	48,24	34,61	71,76%	0,00%	US$ 50,50 B	25,09%
FMS	20,85	0,95	4,56%	2,94%	US$ 15,70 B	3,48%
PHG	92,60	2,21	2,38%	3,16%	US$ 26,49 B	1,45%
HUM	20,85	1,87	8,97%	1,25%	US$ 34,21 B	1,30%
RMD	27,69	6,82	24,62%	0,79%	US$ 40,67 B	27,88%
CNC	17,57	0,70	3,96%	0,00%	US$ 19,12 B	0,59%

comparison of TMDX with indexes

If you had invested (change) 2 years years ago, ago, today you would have

R$ 1.000,00 in PETR4 you would have R$ 2.294,60

R$ 1.000,00 in LEVE3 you would have R$ 5.240,60

*The value considers the reinvestment of dividends.

Dividend History TMDX

current DY: 0,00%

5-year average DY: 0,00%

no dividend paid in the period.

ABOUT THE COMPANY TransMedics Group

TransMedics Group Inc.

Average user rating I10

4.0 (31 people)

Estados Unidos

7 years

Foundation: 2018

2019

Year of debut on the stock exchange - 6 years

110

Employees

The Company TransMedics Group Inc. (Estados Unidos), is listed on Nasdaq with a market value of $ 3,93 Billions, having a net worth of $ 318,10 Milhões.

With a total of 110 employees, the company is listed in the sector of Health and categorized in industry of Medical Supplies and Equipment.

In the last 12 months the Company had a revenue of $ 579,90 Milhões, which generated a profit in the amount of $ 102,36 Milhões.

As for its main indicators, the Company has a P/E ratio of 38,43, a P/BV ratio of 12,37 and in the last 12 months the Company did not pay dividends.

The Company is traded internationally through the ticker TMDX.

Market value

US$ 3,93 Billions

Net worth

US$ 318,10 Milhões

US$ 318.100.000,00

Assets

US$ 890,52 Milhões

US$ 890.520.000,00

Total Number of Shares

34,00 Milhões

34.000.000

Average Daily Trading Volume

US$ 1,06 Million

US$ 1.064.779,42

Sector

Health

Industry

Medical Supplies and Equipment

TMDX

TMDX revenue and profits

TMDX results

DRAG THE FRAME TO SEE MORE DATA

TMDX cash flow

DRAG THE FRAME TO SEE MORE DATA

Discover more assets

LBPSW - 4D pharma

US$ - -0,00% (12M)

P/L

0,00

0,00%

ROE

-300,00%

P/VP

0,00

CVS - CVS Health

US$ 77,90 23,33% (12M)

P/L

17,95

3,43%

ROE

7,05%

P/VP

1,27

CI - Cigna

US$ 300,73 --12,51% (12M)

P/L

14,24

1,91%

ROE

14,37%

P/VP

2,05

CNC - Centene

US$ 35,76 --50,64% (12M)

P/L

17,57

0,00%

ROE

3,96%

P/VP

0,70

HUM - Humana

US$ 280,22 10,41% (12M)

P/L

20,85

1,25%

ROE

8,97%

P/VP

1,87

SNY - Sanofi

US$ 48,09 --8,62% (12M)

P/L

7,88

4,35%

ROE

19,52%

P/VP

1,54

HCA - HCA Healthcare

US$ 415,14 5,77% (12M)

P/L

16,16

0,66%

ROE

-513,25%

P/VP

-82,92

LLY - Eli Lilly

US$ 833,49 --9,64% (12M)

P/L

54,65

0,69%

ROE

75,21%

P/VP

41,10

LBPSW - 4D pharma

US$ - -0,00% (12 M)

P/L

0,00

0,00%

ROE

-300,00%

P/VP

0,00

CVS - CVS Health

US$ 77,90 23,33% (12 M)

P/L

17,95

3,43%

ROE

7,05%

P/VP

1,27

CI - Cigna

US$ 300,73 --12,51% (12 M)

P/L

14,24

1,91%

ROE

14,37%

P/VP

2,05

CNC - Centene

US$ 35,76 --50,64% (12 M)

P/L

17,57

0,00%

ROE

3,96%

P/VP

0,70

HUM - Humana

US$ 280,22 10,41% (12 M)

P/L

20,85

1,25%

ROE

8,97%

P/VP

1,87

SNY - Sanofi

US$ 48,09 --8,62% (12 M)

P/L

7,88

4,35%

ROE

19,52%

P/VP

1,54

HCA - HCA Healthcare

US$ 415,14 5,77% (12 M)

P/L

16,16

0,66%

ROE

-513,25%

P/VP

-82,92

LLY - Eli Lilly

US$ 833,49 --9,64% (12 M)

P/L

54,65

0,69%

ROE

75,21%

P/VP

41,10

Frequently Asked Questions

What is the price of TransMedics Group (TMDX) today?

The price of TransMedics Group (TMDX) today is US$ 107,29, with a variation of -21.05% compared to the last year. The price of TransMedics Group (TMDX) started the year trading around US$ 62,35 and today it is at US$ 107,29. Follow the real-time price chart, the historical price of TransMedics Group (TMDX), and stock data from Ibovespa and international markets.

When does TransMedics Group (TMDX) pay dividends?

TransMedics Group (TMDX) did not distribute dividends in the last year.

TransMedics Group (TMDX) is it worth it?

Currently, TransMedics Group (TMDX) is priced at US$ 107,29, with a P/E of 38,43%, representing a deviation of -2,33% from its historical average P/E. In the last year, the stock showed a variation of -21.05% in its price and distributed US$ 0,00 in dividends, resulting in a Dividend Yield of 0,00%. The total shareholder return was -21,05%.

It is important to remember that past performance does not guarantee future results. This should not be seen as an investment recommendation.

How to buy stocks of TransMedics Group (TMDX)?

Investing in stocks of TransMedics Group (TMDX) can be done in two ways: by buying the stock no exterior. A stock is the original stock, traded on international exchanges. By buying it, you invest with money outside Brazil, which brings greater geographical and currency diversification.

BDR is a receipt for that stock, traded on the B3 with reais, through a brazilian brokerage. Although the money remains in Brazil, the BDR still offers diversification, as it represents a foreign company and is linked to the dollar.

How much do 100 stocks of TransMedics Group (TMDX) yield today?

The yield of TransMedics Group (TMDX) was -0,46% in the last month, -21,05% in the last year and 0,00% in the last 5 years (already considering appreciation and dividends).

In the last 12 months, the company paid a total of US$ 0,00 in dividends, um Dividend Yield de 0,00%.

If you wanted to buy 100 stocks of TransMedics Group (TMDX) today, the total investment would be US$ 10.729,00, based on the current price of US$ 107,29.

If past performance were to repeat, the return on your investment would be:

In 1 year: US$ 8.470,55
In 5 years: US$ 10.729,00
In 10 years: 10.729,00

It is important to remember that past performance does not guarantee future results. This should not be seen as an investment recommendation.

TMDX

TransMedics Group Inc.

Price

variation (12m)

p/l

p/vp

DIVIDEND YIELD

Profitability of TMDX

check out the fundamentals of TransMedics Group shares

P/E

P/SALES RATIO (PSR)

P/BV

DIVIDEND YIELD (DY)

ROA

ROE

ROIC

NET MARGIN

GROSS MARGIN

OPERATING MARGIN

P/EBITDA

P/EBIT

P/ASSET

BVPS

EPS

EQUITY / ASSETS

CAGR REVENUES 5 YEARS

CAGR PROFITS 5 YEARS

Graham's Fair Price

If you had invested (change) 2 years years ago, ago, today you would have

current DY: 0,00%

5-year average DY: 0,00%

ABOUT THE COMPANY TransMedics Group

TransMedics Group Inc.

Estados Unidos

7 years

2019

110

PROFIT X PRICE TMDX

TMDX results

TMDX cash flow

evolution of assets - TMDX

TMDX balance sheet

LBPSW - 4D pharma

CVS - CVS Health

CI - Cigna

CNC - Centene

HUM - Humana

SNY - Sanofi

HCA - HCA Healthcare

LLY - Eli Lilly

LBPSW - 4D pharma

CVS - CVS Health

CI - Cigna

CNC - Centene

HUM - Humana

SNY - Sanofi

HCA - HCA Healthcare

LLY - Eli Lilly

Frequently Asked Questions